Last reviewed · How we verify

NCT06679504

Laparoscopic Totally Extraperitoneal Inguinal Hernia Repair With Fibrin Glue Versus Tack Mesh Fixation

Completed Last updated 12 November 2024
What this trial tests

trial testing Fibrin glue fixation in Inguinal Hernia in 80 participants. Completed in 30 June 2024.

Timeline
1 July 2022
Primary endpoint
15 December 2023
30 June 2024

Quick facts

Lead sponsorSuez Canal University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date1 July 2022
Primary completion15 December 2023
Estimated completion30 June 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Suez Canal University

Who can join

Adults 18 to 60, any sex, with Inguinal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The quality of life after hernia surgery like chronic pain and discomfort has frequently been reported with a frequency varying from 0 to 53%. As many as 10% of the patients report increased pain following surgery. Therefore, the current study aimed to assess the quality-of-life for patients with post-inguinal hernia repair by mesh fixation versus fibrin glue.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Quality of life after laparoscopic totally extraperitoneal (TEP) inguinal hernia repair with fibrin glue versus tack mesh fixation.
    Anwar A, Ghareeb WM, Yasser O, Shaban H, et al · · 2025 · PMID 41271995 · DOI 10.1038/s41598-025-26626-5

Verify or expand the search:

Other recruiting trials for Inguinal Hernia

Currently open trials in the same condition.

Other Suez Canal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06679504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing